Food

Snail Games Partners with Loric Games to Bring Echoes of Elysium to Market

CULVER CITY,Calif.,Dec. 17,2024--Snail,Inc. (Nasdaq: SNAL) ("Snail Games" or the "Company"),a leading global independent developer and publisher of interactive digital entertainmen

12-18

WiMi Develops a New Design Solution for Simulating Quantum Computing Concepts Using FPGA

BEIJING,Dec. 17,2024-- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"),a leading global Hologram Augmented Reality ("AR") Technology provider,today anno

12-18

Adrian Butler Elected to PRA Group Board of Directors

The chief technology officer at Foot Locker,Butler brings more than 25 years of leadership experience across all areas of technology to the Board

12-18

U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well as adults with Crohn\'s disease (CD) and ulcerative coliti

12-18

China National Silk Museum Unveils "Silk and Silk Roads: From Hangzhou to Samarkand" Exhibition in Uzbekistan

SAMARKAND,Uzbekistan,Dec. 12,2024--On December 6,2024,the China National Silk Museum launched the third thematic exhibition "Silk and Silk Roads: From Hangzhou to Samarkand" at the Samarkand

12-18 China National Silk Museum

Luohu of Shenzhen: A Magnet for Global Investments

SHENZHEN,China,Dec. 12,2024-- Saint-Gobain Group,a global leader in lightweight and sustainable construction solutions,reinvested in the Luohu district of Shenzhen this year.

12-18 Shenzhen Luohu District Publicity Department

Lichen China Limited Announces $2.70 Million Registered Direct Offering

XIAMEN,China,Dec. 13,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it

12-18 Lichen China Limited

Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024

SUZHOU,China,Dec. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with

12-18 Alphamab Oncology

Global Times: Top meeting maps out plan for economic work in 2025

BEIJING,Dec. 13,2024-- The annual Central Economic Work Conference was held in Beijing from Wednesday to Thursday as Chinese leaders decided priorities for the economic work in 2025,according to theXi

12-18 Global Times

WeBank Recognized on CNBC Best Banks Asia-Pacific 2024

SHENZHEN,China,Dec. 13,2024-- Recognized for its resilience,adaptability,trustworthiness and reliability,WeBank is selected to the CNBC 2024 list of the Best Banks Asia-Pacific in China.

12-18 WeBank Co. Ltd.